Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?


Omeros Corp. Spikes on Stock Upgrade

By  +Follow September 16, 2013 7:36AM
Tickers Mentioned:

Omeros Corp. (OMER) jumped over 60 percent on early trading after Wedbush raised its price target for the stock. The rise constituted Monday's biggest jump for Omeros since October of 2009, and came with especially heavy volume for the small-cap pharma company. With gains reaching over 64 percent, it was a big day for investors in the Seattle-based company that had seen shares bleed off almost 47 percent of their value over the last year.

Wedbush analysts expressed confidence in OMS302, a new drug being developed for use in ophthalmological procedures like cataracts surgeries. With the Food and Drug Administration clamping down on “homebrew” topical solutions used during intraocular lens replacement surgeries, OMS302 appears poised to be the only solution on the market that combines pain relief and pupil dilation.

Wedbush analyst Liana Moussatos was bullish on Omeros, reiterating an outperform rating while raising the price target to $28.

“We recently had a conversation with a high-volume cataract surgeon about the changing regulatory landscape following sterility issues at compound pharmacies. The FDA has indicated that each patient must be given a separate bottle for topical NSAIDs and mydriatic agents. In addition, surgeons are no longer allowed to mix their own homebrews of these agents for use during surgery—a common practice," she said. "The net impact is that the cost of topical NSAIDs and mydriatic agents per cataract procedure is rising—making not only the cost of OMS302 (we estimate ~$250/procedure in the U.S.) to be closer to topical agents, but also making it the only product combining pain relief and mydriasis which complies with these new regulations."

Approval of OMS302 is expected by the middle of next year, and Moussatos has estimated a 90 percent chance the drug gets the final go-ahead. The positive news about the outlook for OMS302 comes on the heels of last week’s news of positive data from phase 1 clinical trials for another Omeros drug, OMS824, an enzyme inhibitor intended for use in patients with Huntington’s disease and schizophrenia.


(image ocourtesy of Flickr)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.

Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for OMER
30 Aug 14 03:04:35
Weekly SmallCap #Stocks Trend $RSH $ENZN $RPRX $CLUB $EXPR $ARO $ISIS $RALY $OMER $BDSI $GDP $ATRS more@ http://t.co/Giravo3fg9
Market Monitor
29 Aug 14 14:38:45
$OMER: Investors Watch List: Omeros Corporation (NASDAQ:OMER), Yandex N.V. ... http://t.co/I9CPQy9849 http://t.co/hGIbMFJCCf
29 Aug 14 14:30:32
Omeros Corporation (OMER) Jumps 5.07% on August 29 $OMER http://t.co/KTiObwhdjK
Daily Contracts
29 Aug 14 13:46:01
Real-Time feed of company contracts, original agreements and executive updates from Omeros Corp. $OMER http://t.co/OUYnDjeICP
29 Aug 14 13:01:44
SmallCap #Stocks Trend $RALY $RSH $BEBE $PACB $NAVB $TQNT $ATRS $RFMD $ENZN $BLOX $CODE $CLUB $OMER more@ http://t.co/Giravo3fg9
29 Aug 14 12:31:07
RSII shot up over 100% today! Major Update: http://t.co/GMnQioznZp $OMER $TACT $ORAN
29 Aug 14 08:54:36
$OMER breaking out of trading range on way to $16-18 range
28 Aug 14 02:08:47
How to Pick Winning Biotechs Before the Herd $LJPC $galt $icpt $XOMA $UTHR $PCRX $ALXN $OMER http://t.co/F8L9PIvAHO
Market Compass
27 Aug 14 20:38:53
$OMER: Omeros (OMER) Enters Overbought Territory http://t.co/nCc7boVrhk http://t.co/oIJuowWf7Z
27 Aug 14 20:36:46
REVI closed up 44.5% today! Special Update: http://t.co/6o15AzsDr3 $OMER $TACT $ORAN
27 Aug 14 19:48:19
First idea for tomorrow is $OMER .. Strong MACD cross and nice uptrend.. http://t.co/4FXuTQyL95
27 Aug 14 01:09:41
We are Releasing a SECRET Penny Stock Pick Today! Get it early: https://t.co/pOvMqLbReN $OMER $TACT $ORAN
26 Aug 14 22:07:13
http://t.co/hjgLwIcNgz Emylers: $OMER Up to date company activities and other: Emylers http://t.co/wdTwnia7zX http://t.co/hjgLwIcNgz
26 Aug 14 22:07:11
http://t.co/QkCFZ8H3V8 Emylers: $OMER Up to date company activities and other: Emylers http://t.co/wGhj9upcFj http://t.co/QkCFZ8H3V8
Ben Silverberg
26 Aug 14 16:48:38
$OMER confirmed B/O Continuation Wedge, S 13.55, close above R 14.31 on way to 15.92, PT 19.00-20.50 http://t.co/ctXYDTMEOg
Biz News Pioneer
26 Aug 14 16:38:39
$OMER: Omeros Corporation Estimates May Vary http://t.co/zHyOkl5Qtc http://t.co/tiiKxs98PH
26 Aug 14 15:44:01
Omeros Corporation (OMER) Jumps 5.62% on August 26 $OMER http://t.co/sOtaK06uzH
Phil Martin
26 Aug 14 14:23:40
$OMER http://t.co/V3Pgrqu4uf
26 Aug 14 13:53:58
$OMER up 5.6% to 14.09 after bullish trade setup #stocks #options #trading http://t.co/ioOLeHYkhu
$$$ Money $$$
26 Aug 14 11:01:55
$OMER sleeper waken up after the sell off. Nice three days action
Day Trade Alerts
26 Aug 14 09:52:46
via #AlertTrade Price Action Alert $OMER - OMEROS #stocks #intraday http://t.co/VS8RO1bzXJ
Stock News Guru
26 Aug 14 09:38:44
$OMER: Monday’s Top Biotech Stories: Ariad, Omeros, NPS Pharmaceuticals, and Shire http://t.co/MN1yywqsKx http://t.co/mX6e4wlaRv
Investors Hangout
26 Aug 14 09:31:58
Emylers: $OMER Up to date company activities and other http://t.co/yhUMpyZeLQ
Investors Hangout
26 Aug 14 09:31:48
Emylers: $OMER Up to date company activities and other http://t.co/LBTJS50EaS
Investors Hangout
26 Aug 14 09:31:10
DennyT: ARIA Insider Roster $ARIA $TNA $X $OMER $GE http://t.co/bHd6NX8Roz
Investors Hangout
26 Aug 14 09:31:10
DennyT: ARIA Insider Roster $ARIA $TNA $X $OMER $GE http://t.co/ZhbKm1SHKw
Extreme Stocks
26 Aug 14 09:25:22
Emylers: $OMER Up to date company activities and other http://t.co/wTGYPAhaMm
26 Aug 14 09:17:45
$OMER Up to date company activities and other important information about $OMER http://t.co/wFMPXpJS5g
Market Monitor
26 Aug 14 08:38:45
$OMER: Omeros' Omidria Gets FDA Nod http://t.co/XfXobvx2l9 http://t.co/7KM9xz9HVD
Investors Hangout
26 Aug 14 07:55:31
leahanne: $OMER Omeros Corp (OMER) 13.80 +0.46 (+3.45%) http://t.co/fQkeSZIHqU
Investors Hangout
26 Aug 14 07:54:53
leahanne: $OMER Omeros Corp (OMER) 13.80 +0.46 (+3.45%) http://t.co/iD692fkI0q
26 Aug 14 07:40:24
$OMER Omeros Corp (OMER) 13.80 +0.46 (+3.45%) $XLY $SMH $PANW http://t.co/Chd75TypFq
Daily Contracts
26 Aug 14 06:35:01
Real-Time feed of company contracts, original agreements and executive updates from Omeros Corp. $OMER http://t.co/OUYnDjeICP
26 Aug 14 01:56:06
$MCET closed up 57% yesterday. Platinum Members once saw 235% gains on it, in 1 week: https://t.co/9OxPSiatev $OMER $TACT $ORAN
Phil Martin
25 Aug 14 16:52:45
$OMER http://t.co/1PhfqIoy9b
Ben Silverberg
23 Aug 14 07:03:09
Watch for upside MoMo after Friday's Bullish Engulfing Candle in $AZPN $OMER $ENV $PLUG $YY $DRII
By  +Follow September 16, 2013 7:36AM



blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.